Alpha 2.0
Login Register
» Articles » PMID: 8094889

2-Chlorodeoxyadenosine for Patients with B-cell Chronic Lymphocytic Leukemia Resistant to Fludarabine

Overview
Journal N Engl J Med
Specialty General Medicine
Date 1993 Mar 18
PMID 8094889
Citations 6
Authors
A Saven
R H Lemon
L D Piro
Affiliations
Soon will be listed here.
Citing Articles

Alemtuzumab in the treatment of fludarabine refractory B-cell chronic lymphocytic leukemia (CLL).

Montillo M, Ricci F, Miqueleiz S, Tedeschi A, Morra E Biologics. 2009; 2(1):41-52.

PMID: 19707426 PMC: 2727786. DOI: 10.2147/btt.s1397.

Management of chronic lymphocytic leukaemia.

Kalil N, Cheson B Drugs Aging. 2000; 16(1):9-27.

PMID: 10733261 DOI: 10.2165/00002512-200016010-00002.

Phase I/II evaluation of pentostatin (2'-deoxycoformycin) in a five day schedule for the treatment of relapsed/refractory B-cell chronic lymphocytic leukaemia.

Johnson S, Catovsky D, Child J, Newland A, Milligan D, Janmohamed R Invest New Drugs. 1998; 16(2):155-60.

PMID: 9848579 DOI: 10.1023/a:1006100900082.

Clinical and toxicological aspects of the antineoplastic drug cladribine: a review.

Guchelaar H, Richel D, Schaafsma M Ann Hematol. 1994; 69(5):223-30.

PMID: 7948311 DOI: 10.1007/BF01700276.

Current approaches to the treatment and management of chronic lymphocytic leukaemia.

Montserrat E, Rozman C Drugs. 1994; 47 Suppl 6:1-9.

PMID: 7525184 DOI: 10.2165/00003495-199400476-00003.